Working Hours
7 Days a Week
Location
Klokkargårdsbakken 35, 9019 Tromsø, Norway
Making effective cancer drugs available faster
3D cell migration assay platform for cancer drug screening and validation
About us
Cymoplive is a 3D cell migration assay platform for cancer drug screening and validation derived from the Horizon Europe EIC FET Open project OrganVision from UiT The Arctic University of Norway. Cymoplive can provide better predictability of successful cancer drugs, and reduce time/resources for drug discovery and animal testing. We’re looking to validate Cymoplive in the lead optimization phase in pre-clinical screening for soft tissue cancer.
The battle against cancer is a tough one.. The biggest weapon in our arsenal is the anti-cancer drugs. But more than 95% of the drugs that enter clinical trials, fail. “
WELCOME TO OUR Cymoplive Technology
Sed erat libero, porta sed quam sed, vulputate tincidunt tortor.
Why is Cymoplive Unique
Sed erat libero, porta sed quam sed, vulputate tincidunt tortor.
Medical Device Development
From concept to commercialization, we specialize in designing cutting-edge medical devices.
Drug Discovery and Development
Discover our research expertise in developing new drugs to combat challenging diseases.
Regulatory Compliance Services
Ensure your products meet all regulatory standards with our comprehensive compliance services.
Data Analysis and Reporting
Harness the power of data analytics to drive informed decision-making in your medical research projects.
WHY CHOOSE US
Improved success rate of cancer drug discovery
Tests cancer drugs on its deadliest aspect— spreading
Saves millions of animal lives in pre-clinical trials
Saves millions of Euros invested in failed drugs
OUR GALLERY
Sed erat libero, porta sed quam sed, vulputate tincidunt tortor.
